Skip to main content
. 2022 Apr 14;10(4):E354–E360. doi: 10.1055/a-1783-8756

Table 2. Outcomes of colorectal ESD in IBD.

En bloc resection, n (%) 43 (95.5 %)
R0 resection, n (%) 34 (75.5 %)
Histology, n (%)

  • Serrated adenomas/polyps

 4 (8.9 %)

  • LGD/adenoma

 28 (62.2 %)

  • HGD

 9 (20.0 %)

  • Intramucosal cancer

 1 (2.2 %)

  • Invasive cancer

 3 (6.7 %) 1
Adverse events; n (%)

  • Intraprocedural perforation

 1 (2.4 %)

  • Severe intraprocedural bleeding

 0

  • Delayed perforation

 0

  • Delayed bleeding

 4 (9.8 %)
Local recurrence on follow-up endoscopy; n (%) 1/38 (2.6 %)

ESD, endoscopic submucosal dissection; IBD, inflammatory bowel disease; LGD, low-grade dysplasia; HGD, high-grade dysplasia.

1

Superficial invasive cancer; all lesions were curatively resected by ESD.